CPSF2 Rekombinanter Antikörper
CPSF2 Rekombinant Antikörper für WB, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
251387H5
Kat-Nr. : 86513-3-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86513-3-PBS bindet in WB, IF/ICC, Indirect ELISA CPSF2 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | CPSF2 fusion protein Ag11950 |
| Vollständiger Name | cleavage and polyadenylation specific factor 2, 100kDa |
| Berechnetes Molekulargewicht | 782 aa, 88 kDa |
| Beobachtetes Molekulargewicht | 110 kDa |
| GenBank-Zugangsnummer | BC070095 |
| Gene symbol | CPSF2 |
| Gene ID (NCBI) | 53981 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Cleavage and Polyadenylation Specificity Factor Subunit 2 (CPSF2) is a critical component of the mRNA 3′ end processing machinery, playing a pivotal role in the cleavage and polyadenylation of pre-mRNA. This process is essential for the stability, nuclear export, and translation efficiency of mRNA, making CPSF2 a key player in gene expression regulation. Recent studies have highlighted the significance of CPSF2 in various diseases, particularly cancer. It's reported that in papillary thyroid carcinoma (PTC), negative expression of CPSF2 has been associated with poorer clinical outcomes, including higher rates of cervical lymph node metastasis, distant metastasis, and reduced recurrence-free survival. (PMID:26148673)





